JAC-Antimicrobial Resistance · 2021 · 11 citations · 13 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibiotic ResistanceMycobacterial DiagnosticsPulmonary TuberculosisTuberculosis DiagnosisTuberculosis Diagnostic TestingTuberculosis EpidemiologyAdult CasesDrug Resistance TestingGenexpert Mtb And Rif TestingLaboratory InvestigationsMolecular Drug Susceptibility TestingMycobacterium Tuberculosis InfectionPhenotypic Drug Susceptibility TestingRifampicin Resistance Testing
Abstract Background In a 12 month period, three Irish-born adult cases with pulmonary TB were initially diagnosed by Xpert® MTB/RIF Ultra assay, which detected a rifampicin resistance-conferring mutation prompting treatment as potential MDR cases. Methods Further laboratory investigations on the cultured isolates included GenoType MTBDRplus assay, phenotypic drug susceptibility tests using the BD BACTEC MGIT culture system and MIC broth microdilution tests. Sequencing of the rpoB gene was performed using Sanger sequencing and WGS. Results Phenotypic drug susceptibility tests determined the isolates to be rifampicin susceptible. Molecular investigations identified an A451V (codon 532) mutation in the Mycobacterium tuberculosis rpoB gene that has not previously been found to cause rifampicin resistance. Genome sequencing revealed that the three isolates’ genomes differed by ≤5 SNPs, indicating a high likelihood of recent transmission events. Furthermore, a cluster of six related M. tuberculosis isolates from our in-house typing database showed four were highly related; all were rifampicin susceptible and lacked this mutation. Conclusions False detection of rifampicin resistance, albeit rare, should be considered possible with Xpert® MTB/RIF Ultra assay, particularly in low TB incidence settings. Confirmatory sequencing methods should be performed to prevent the unnecessary use of second-line anti-tuberculous drugs.
13
Philip Supply, Caroline Allix, Sarah Lesjean et al. · Journal of Clinical Microbiology · 2006 · 1.3K citations
Soumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki et al. · mBio · 2017 · 657 citations · Full text
Caroline Allix‐Béguec, Dag Harmsen, Thomas Weniger et al. · Journal of Clinical Microbiology · 2008 · 395 citations · Full text